Published On: Wed, Apr 7th, 2021
Published in Category: Rawalpindi

Al-Shifa embarks on the final trial of new Chinese vaccine

Share This

Rawalpindi: Final trials of corona vaccine developed by Chinese multinational, Anhui ZhifeiLongcom Biopharmaceutical Co. Ltd has been initiated in the Al-Shifa Trust Eye Hospital, after which it will be made available to the masses across Pakistan.

The vaccine has already been approved by the Government of China, while trials have been started in Al-Shifa after Drug Regulatory Authority of Pakistan (DRAP) recommended its Rawalpindi facility for the purpose.

After successful completion of phase 1 and phase 2 of the trials, the third and final phase has been initiated today after the signing of an agreement between Al-Shifa Trust and the Chinese company.

According to the agreement, ZhifeiLongcom will be responsible for providing investigational drug and clinical material which meets the requirements while supervising and managing the trial process.

For the purpose, a state-of-the-art Clinical Research Unit has already been established in Al-Shifa Trust Eye Hospital and trials will be completed in three months with the help of one thousand volunteers.